Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Revenue

Stoke Therapeutics had revenue of $158.57M in the quarter ending March 31, 2025, with 3,661.12% growth. This brings the company's revenue in the last twelve months to $190.91M, up 2,333.81% year-over-year. In the year 2024, Stoke Therapeutics had annual revenue of $36.56M with 316.34% growth.

• Revenue (ttm): $190.91M
• Revenue Growth: +2,333.81%
• P/S Ratio: 3.45
• Revenue / Employee: $1,491,469
• Employees: 128
• Market Cap: 632.23M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	36.56M	27.78M	316.34%
Dec 31, 2023	8.78M	-3.63M	-29.22%
Dec 31, 2022	12.41M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.